311770-92-0

Basic information

• Product Name: methyl 3-(3-carboxy-4-methoxyphenyl)-2,2-dimethylpropanoate
• Synonyms: methyl 3-(3-carboxy-4-methoxyphenyl)-2,2-dimethylpropanoate
• CAS NO: 311770-92-0
• Molecular Weight: 266.294
• Mol File: 311770-92-0.mol

Chemical Properties

• CAS DataBase Reference: methyl 3-(3-carboxy-4-methoxyphenyl)-2,2-dimethylpropanoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 3-(3-carboxy-4-methoxyphenyl)-2,2-dimethylpropanoate(311770-92-0)
• EPA Substance Registry System: methyl 3-(3-carboxy-4-methoxyphenyl)-2,2-dimethylpropanoate(311770-92-0)

Safety Data

• Hazardous Substances Data: 311770-92-0(Hazardous Substances Data)

Upstream product

• 311770-84-0 benzyl 5-acetoxymethyl-2-methoxybenzoate 
• 311770-87-3 benzyl 5-hydroxymethyl-2-methoxybenzoate 
• 311770-86-2 benzyl 5-formyl-2-methoxybenzoate 
• 84923-70-6 5-formyl-2-methoxybenzoic acid 
• 311770-90-8 methyl 3-(3-benzyloxycarbonyl-4-methoxyphenyl)-2,2-dimethylpropanoate 

Downstream Products

• 311770-95-3 methyl 3-(4-methoxy-3-[N-((4-(trifluoromethyl)phenyl)methyl)carbamoyl]phenyl)-2,2-dimethylpropanoate 

Relevant articles and documents

Design, synthesis, and evaluation of substituted phenylpropanoic acid derivatives as human peroxisome proliferator activated receptor activators. Discovery of potent and human peroxisome proliferator activated receptor α subtype-selective activators

Substituted phenylpropanoic acid derivatives were prepared as part of a search for subtype-selective human peroxisome proliferator activated receptor α (PPARα) activators. Structure-activity relationship studies indicated that the nature and the stereoche

Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor (PPAR) α

The invention provides novel substituted phenylpropanoic acid derivatives that activate by binding to receptor as ligands of human peroxisome preliferant-activated receptor α (PPARα), and exhibit potent decreasing action on lipids in blood (cholesterol an

SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES AS AGONISTS TO HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA(PPAR)

The invention provides novel substituted phenylpropanoic acid derivatives that activate by binding to receptor as ligands of human peroxisome preliferant-activated receptor α (PPARα), and exhibit potent decreasing action on lipids in blood (cholesterol and triglyceride). It relates to substituted phenylpropanoic acid derivatives represented by a general formula (1), their pharmaceutically acceptable salts and their hydrates, and processes for preparing them.